Adverse effect of other viral vaccines, subsequent encounter

This code signifies an adverse reaction to a viral vaccine other than those specifically classified elsewhere (e.g., COVID-19, influenza). It indicates that the patient is receiving ongoing care for the sequelae of this adverse effect. The reaction could encompass a range of systemic or localized responses.

Apply this code when a patient presents for follow-up care, monitoring, or treatment related to an adverse effect from a viral vaccine, excluding specified types. This is appropriate for subsequent visits after the initial diagnosis and treatment plan for the adverse reaction has been established. Examples include ongoing management of myocarditis, Guillain-Barré syndrome, or severe allergic reactions attributed to a viral vaccine.

• Always use in conjunction with a code for the specific adverse effect experienced by the patient.
• Ensure the encounter is for follow-up care, not the initial presentation, due to the "subsequent encounter" designation.
• Verify that the vaccine administered was a viral vaccine and not another type (e.g., bacterial, toxoid) to ensure accurate code selection.